CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation
Yingzi Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lunan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 12
Related Papers
The prevalence of antibodies to SARS-CoV-2 among blood donors in China
|Nature Communications|2021|64
Discovery of the improved antagonistic prolactin variants by library screening
|Protein Engineering Design and Selection|2011|9